Get the Stockscreener App
69.68
2.27%
-1.62
Pre-market:
70.01
0.33
+0.47%
Globus Medical Inc stock is traded at $69.68, with a volume of 1.93M.
It is down -2.27% in the last 24 hours and down -17.18% over the past month.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
See More
Previous Close:
$71.30
Open:
$71.37
24h Volume:
1.93M
Relative Volume:
1.67
Market Cap:
$9.58B
Revenue:
$2.48B
Net Income/Loss:
$91.51M
P/E Ratio:
104.00
EPS:
0.67
Net Cash Flow:
$293.77M
1W Performance:
-8.69%
1M Performance:
-17.18%
6M Performance:
-0.10%
1Y Performance:
+25.89%
1-Day Range:
$68.88
$72.15
1-Week Range:
$68.88
$78.09
52-Week Range:
$49.33
$94.93
Globus Medical Inc Stock (GMED) Company Profile
Name
Globus Medical Inc
Sector
Industry
Phone
610-930-1800
Address
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
69.68 | 9.58B | 2.48B | 91.51M | 293.77M | 0.67 |
|
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | BofA Securities | Underperform → Neutral |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-07-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| May-20-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-18-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-19-23 | Upgrade | Stifel | Hold → Buy |
| Mar-30-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-13-23 | Downgrade | BofA Securities | Buy → Underperform |
| Feb-10-23 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-10-23 | Downgrade | Loop Capital | Buy → Hold |
| Feb-10-23 | Downgrade | Needham | Buy → Hold |
| Feb-10-23 | Downgrade | Truist | Buy → Hold |
| Feb-10-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-28-22 | Initiated | Wells Fargo | Overweight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-13-21 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-29-21 | Initiated | Loop Capital | Buy |
| Feb-18-21 | Resumed | Needham | Buy |
| Dec-08-20 | Initiated | Citigroup | Buy |
| Oct-20-20 | Initiated | Stifel | Hold |
| Aug-06-20 | Reiterated | Needham | Buy |
| Aug-06-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jul-21-20 | Initiated | Northland Capital | Market Perform |
| Jul-06-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-08-20 | Reiterated | Needham | Buy |
| Mar-18-20 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-12-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Aug-02-19 | Reiterated | Needham | Buy |
| May-24-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| May-03-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Upgrade | UBS | Neutral → Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-27-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jun-01-18 | Initiated | Cantor Fitzgerald | Overweight |
| May-03-18 | Reiterated | Needham | Buy |
| Apr-04-18 | Upgrade | Needham | Hold → Buy |
View All
Globus Medical Inc Stock (GMED) Latest News
Globus Medical Introduces Advanced Solutions for ALIF Surgery - MyChesCo
Globus Medical (NYSE:GMED) Stock Rating Upgraded by StockNews.com - Defense World
Globus Medical introduces new spine surgery solutions By Investing.com - Investing.com Canada
Globus Medical introduces new spine surgery solutions - Investing.com India
Globus Medical Launches Innovative COHERE™ ALIF Spacer and Modulus™ ALIF Blades for Spine Surgery - Nasdaq
Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio ... - Bluefield Daily Telegraph
Globus Medical extends versatility of Advanced Materials - GlobeNewswire
Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades - GlobeNewswire Inc.
Hip Replacement Market Report and Company Analysis 2025-2033 Featuring Smith & Nephew, J&J, Integra, Zimmer Biomet, Stryker, B. Braun Melsungen, Globus Medical, MicroPort Scientific, Conformis - OrthoSpineNews
OsteoCentric Technologies Enters into a Non-Exclusive Licensing Agreement with Globus Medical - The Malaysian Reserve
Implantable Medical Devices Market growing at a CAGR of 7.2% from 2021 to 2030 | CONMED Corporation, Globus - EIN News
Hip Replacement Market Report and Company Analysis - GlobeNewswire
Medical Devices & SuppliesSpecialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers - Yahoo Finance
Globus Medical to Showcase Cutting-Edge Innovations at 2025 AAOS Meeting - MSN
Proficio Capital Partners LLC Buys Shares of 14,392 Globus Medical, Inc. (NYSE:GMED) - Defense World
Globus Medical to feature ExcelsiusFlex™ for Total Knee - GlobeNewswire
Globus Medical to Showcase Innovative Technologies at 2025 AAOS Annual Meeting in San Diego - Nasdaq
Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of ... - Bluefield Daily Telegraph
Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic - EIN News
Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference - GlobeNewswire
Can Globus Medical's Conference Presentation Reveal New Growth Strategy? - StockTitan
Is the Options Market Predicting a Spike in Globus Medical (GMED) Stock? - MSN
There May Be Reason For Hope In Globus Medical's (NYSE:GMED) Disappointing Earnings - Simply Wall St
Globus Medical's (NYSE:GMED) Soft Earnings Don't Show The Whole Picture - Yahoo Finance
Private Advisor Group LLC Boosts Stake in Globus Medical, Inc. (NYSE:GMED) - Defense World
Globus Medical’s Earnings Call: Record Revenue and Growth - TipRanks
Is Globus Medical, Inc. (GMED) the Best Medical Technology Stock to Buy According to Analysts? - Insider Monkey
Globus medical director Ann Rhoads sells $590,100 in stock By Investing.com - Investing.com South Africa
Globus medical director Ann Rhoads sells $590,100 in stock - Investing.com India
Orthobiologics Market Generated Opportunities, Future Scope - openPR
Globus Medical, Inc. (NYSE:GMED) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Globus Medical's SWOT analysis: stock outlook amid acquisition and FDA warning - MSN
Globus Medical to acquire Nevro for $5.85 per share - MSN
Sanctuary Advisors LLC Has $932,000 Position in Globus Medical, Inc. (NYSE:GMED) - Defense World
Globus Medical Reports Record Sales and Strong Growth in 2024 - MSN
Globus Medical's SWOT analysis: stock poised for growth amid challenges - Investing.com
Globus Medical's SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com UK
Spinal Retractor Market: Growth, Trends, Competitive Landscape & Forecast 2025-2032: Stryker, Globus Medical - openPR
Oversold Conditions For Globus Medical (GMED) - Nasdaq
Looking Into Globus Medical's Recent Short Interest - Benzinga
What Analysts Are Saying About Globus Medical Stock - Benzinga
Truist holds Globus Medical stock rating, maintains $90 target By Investing.com - Investing.com South Africa
Here's How Much You Would Have Made Owning Globus Medical Stock In The Last 10 Years - Benzinga
Globus Medical price target raised to $103 from $100 at Barclays - TipRanks
Allworth Financial LP Reduces Stock Position in Globus Medical, Inc. (NYSE:GMED) - Defense World
Needham & Company LLC Reaffirms Hold Rating for Globus Medical (NYSE:GMED) - Defense World
Is Globus Medical, Inc. (NYSE:GMED) Trading At A 32% Discount? - Yahoo Finance
Globus Medical Q4 Earnings & Revenues Top, Margins Expand, Stock Dips - MSN
Globus Medical, Inc. (NYSE:GMED) Q4 2024 Earnings Call Transcript - Insider Monkey
Globus Medical Inc Stock (GMED) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.40%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):